Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan-Dec;15(1):2185031.
doi: 10.1080/19490976.2023.2185031.

Bacterial flagellin is a dominant, stable innate immune activator in the gastrointestinal contents of mice and rats

Affiliations

Bacterial flagellin is a dominant, stable innate immune activator in the gastrointestinal contents of mice and rats

Matam Vijay-Kumar et al. Gut Microbes. 2023 Jan-Dec.

Abstract

Intestinal contents comprise the largest repository of immunogenic ligands of microbial origin. We undertook this study to assess the predominant microbe-associated molecular patterns (MAMPs) present therein and the receptors) that mediate the innate immune responses to them. Here, we demonstrated that intestinal contents from conventional, but not germ-free, mice and rats triggered robust innate immune responses in vitro and in vivo. Such immune responses were abrogated in the absence of either myeloid differentiation factor 88 (MyD88) or Toll-like receptor (TLR) 5, but not TLR4, suggesting that the stimuli was flagellin (i.e., protein subunit of flagella that drives bacterial motility). Accordingly, pre-treating intestinal extracts with proteinase, thereby degrading flagellin, was sufficient to block their ability to activate innate immune responses. Taken together, this work serves to underscore flagellin as a major, heat-stable and bioactive MAMP in the intestinal content that confers this milieu strong potential to trigger innate immune responses.

Keywords: Gut microbiota; IL-10; LPS; MyD88; cytokines; toll-like Receptor-4; toll-like Receptor-5.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
In vivo administration of intestinal extracts from conventional but not germ-free mice induced robust pro-inflammatory cytokine and chemokine responses. Eight-week-old female C57BL/6 mice (n = 5) were administered FE (2.0 mg equivalent of dry feces weight; i.P.) from either conventional (Conv) mice or germ-free (GF) mice. Control mice were given sterile PBS. (a) Body weight (%) at 0 and 24 h post-treatment. After 2 h post-treatment, mice were bled and hemolysis-free sera were analyzed for (b) IL-6, (c) KC, (d) serum amyloid a (SAA) and (e) Lipocalin-2 (Lcn2). Results were expressed as mean ± SEM. Statistical significance calculated using two-tailed Student’s t test for (a) and one-way ANOVA with Tukey’s post-hoc test for (b-e). **p < 0.01, ***p < 0.001.
Figure 2.
Figure 2.
Intestinal extracts from conventional mice failed to induce pro-inflammatory cytokine response in Myd88 deficient mice. Eight-week-old male MyD88-deficient (Myd88KO) mice (n = 5) and their WT littermates (n = 3) were administered FE (2.0 mg equivalent of dry feces weight; i.P.) from conventional mice. Control (Con) mice were given sterile PBS. After 2 h, mice were bled, and hemolysis-free sera were analyzed for (a) IL-6 and (b) KC. Results were expressed as mean ± SEM. Statistical significance calculated using two-way ANOVA with Tukey’s post-hoc test. ***p < 0.01.
Figure 3.
Figure 3.
Intestinal extracts-induced pro-inflammatory response is TLR5-dependent. Eight-week-old male WT, TLR4-deficient (Tlr4KO) or TLR5-deficient (Tlr5KO) mice (n = 3–5) were administered FE (2.0 mg equivalent of dry feces weight; i.P.) from conventional mice. Control (Con) mice were given sterile PBS. After 2 h, mice were bled, and hemolysis-free sera were analyzed for (a&b) IL-6 and KC in WT and Tlr4KO mice and (c&d) IL-6 and KC in WT and Tlr5KO mice. Results were expressed as mean ± SEM. Statistical significance calculated using two-way ANOVA with Tukey’s post-hoc test. ***p < 0.001.
Figure 4.
Figure 4.
The immunogenicity of fecal extract was attributable to flagellin, which can be dampened by proteinase treatment or heightened by heating and depolymerization. (a) Flagellin immunoblot showing the absence and presence of flagellin in germ-free (GF) and conventional (Conv) mouse feces, respectively. (b&c) FE from Conv mice were digested with or without Proteinase K (1 mg/ml) overnight at 37ºC. Samples were boiled for 10 min to inactivate Proteinase K prior to administering to eight-week-old male mice (n = 6) at a dose of 200 µg protein equivalent (i.P.). After 2 h, mice were bled and hemolysis-free sera were analyzed for (b) IL-6 and (c) KC. (d&e) in a separate experiment, eight-week-old female mice (n = 3–5) were challenged with FE (2.0 mg equivalent of dry feces weight; i.P.) that were either semi-processed (SP: without boiling or sonication) or fully processed (FP: with boiling and sonication); see Methods section for details. After 2 h, mice were bled and hemolysis-free sera were analyzed for (d) IL-6 and (e) KC. Results were expressed as mean ± SEM. Statistical significance calculated using two-tailed Student’s t test for (b-c) and one-way ANOVA with Tukey’s post-hoc test for (d-e). **p < 0.01, ***p < 0.001.

References

    1. Sender R, Fuchs S, Milo R.. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. doi:10.1371/journal.pbio.1002533. - DOI - PMC - PubMed
    1. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. Eur J Immunol. 2001;167(4):1882–10. doi:10.4049/jimmunol.167.4.1882. - DOI - PubMed
    1. Raby AC, Le Bouder E, Colmont C, Davies J, Richards P, Coles B, George CH, Jones SA, Brennan P, Topley N, et al. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. Eur J Immunol. 2009;183(1):506–517. doi:10.4049/jimmunol.0802909. - DOI - PubMed
    1. Zunt SL, Burton LV, Goldblatt LI, Dobbins EE, Srinivasan M. Soluble forms of toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-α secretion by macrophage-like cells. Clin Exp Immunol. 2009;156(2):285–293. doi:10.1111/j.1365-2249.2009.03854.x. - DOI - PMC - PubMed
    1. LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M, Griffin GE, Ferrara P, Schiffrin EJ, Morgan BP, et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. Eur J Immunol. 2003;171(12):6680–6689. doi:10.4049/jimmunol.171.12.6680. - DOI - PubMed

Publication types

LinkOut - more resources